Dabrafenib for treating unresectable or metastatic BRAF V600 mutation‑positive melanoma

  • Technology appraisal guidance
  • TA321
  • Published: 
Download (PDF)

What has NICE said?

Dabrafenib (also known as Tafinlar) is recommended. This drug is a possible treatment for people with melanoma that has spread, can't be removed by surgery and is BRAF V600 mutation-positive.

What does this mean for me?

If you have melanoma, and your doctor thinks that dabrafenib is the right treatment, you should be able to have the treatment on the NHS.

  • Information Standard